EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IFN-γ in the tumor microenvironment: dual roles in cancer progression and therapy

Jiahui Cui, Yi Zhang, Li Yang

EXCLI Journal · 14.10.2025 · 24 · 1352-1371

DOI: 10.17179/excli2025-8617 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 14.10.2025. Verfasst von Jiahui Cui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon-gamma (IFN-γ), as a pleiotropic cytokine, plays a pivotal role in antitumor immunity. Its remarkable immunostimulatory, antiproliferative, and pro-apoptotic effects make it a promising candidate for tumor immunotherapy. Here, we highlight the dual role of IFN-γ in the tumor microenvironment during tumor development and treatment. IFN-γ can enhance antigen presentation, boost cytotoxic T cell and natural killer cell activity, and inhibit angiogenesis, promoting tumor regression and correlating with favorable therapeutic outcomes. However, prolonged exposure may induce the upregulation of immune checkpoint molecules such as programmed death-ligand 1, trigger T cell exhaustion, and recruit regulatory T cells, phenomena associated with the development of treatment resistance in cancer therapy. This dual nature poses significant challenges for harnessing IFN-γ in tumor treatment, necessitating an in-depth understanding of its mechanisms within specific microenvironments. Although numerous studies have explored IFN-γ-based tumor therapies, their outcomes have been inconsistent. Thus, although IFN-γ-based therapeutic strategies hold considerable promise, their clinical translation requires precise modulation to fully exploit its antitumor effects while mitigating potential protumor risks.

Schlagwörter

Stichwörter der Autor:innen

IFN-gammaimmunoregulationimmunotherapytumor progressiontumor regression

Autor:innen und Institutionen

  • Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhongyuan Cell Therapy and Immunotherapy Laboratory, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan,…
  • School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.

Zitieren

APA

Cui, J., Zhang, Y., & Yang, L. (2025). IFN-γ in the tumor microenvironment: dual roles in cancer progression and therapy. EXCLI Journal, 24, 1352-1371. https://doi.org/10.17179/excli2025-8617

Vancouver

Cui J, Zhang Y, Yang L. IFN-γ in the tumor microenvironment: dual roles in cancer progression and therapy. EXCLI Journal. 2025;24:1352-1371. doi:10.17179/excli2025-8617

BibTeX
@article{Cui2025,
  author = {Cui, Jiahui and Zhang, Yi and Yang, Li},
  title = {IFN-γ in the tumor microenvironment: dual roles in cancer progression and therapy},
  journal = {EXCLI Journal},
  year = {2025},
  volume = {24},
  pages = {1352--1371},
  doi = {10.17179/excli2025-8617}
}
Kostenlos starten →